Summit Therapeutics (SMMT) Debt Ratio (2022 - 2024)
Summit Therapeutics' (SMMT) quarterly Debt Ratio came in at 0.57 in Q1 2024, up 44.19% YoY from 0.39 in Q2 2023, and up 14.8% on a QoQ basis from 0.49 in Q4 2023.
Summit Therapeutics (SMMT) Debt Ratio (2022 - 2024) Analysis & Trends
Summit Therapeutics (SMMT) has 3 years of Debt Ratio data on file, last reported at 0.57 in Q1 2024.
- Quarterly Debt Ratio rose 44.19% year-over-year to 0.57 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.57 (up 44.19% YoY) and the FY2023 annual result came in at 0.49, down 33.83% from the prior year.
- Debt Ratio grew to 0.57 in Q1 2024, from 0.49 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.74 in Q4 2022 to a low of 0.22 in Q1 2022.
- A 3-year average of 0.44 and a median of 0.42 in 2023 frame the typical range for Debt Ratio.
- The widest YoY moves for Debt Ratio: up 82.37% in 2023, down 33.83% in 2023.
- Tracing SMMT's Debt Ratio over 3 years: stood at 0.74 in 2022, then plunged by 33.83% to 0.49 in 2023, then grew by 14.8% to 0.57 in 2024.
- The last three Debt Ratio figures came in at 0.57 (Q1 2024), 0.49 (Q4 2023), and 0.42 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.57 |
| Dec 31, 2023 | 0.49 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.39 |
| Dec 31, 2022 | 0.74 |
| Jun 30, 2022 | 0.26 |
| Mar 31, 2022 | 0.22 |